| Nombre del producto |
19-Norpregna-5(10),9(11)-diene-3,20-dione,17-hydroxy-, cyclic 3,20-bis(1,2-ethanediyl acetal), (5a,10a)- |
| Nombre en inglés |
19-Norpregna-5(10),9(11)-diene-3,20-dione,17-hydroxy-, cyclic 3,20-bis(1,2-ethanediyl acetal), (5a,10a)-; 19-Norpregna-5(10),9(11)-diene-3,20-dione,17-hydroxy-, cyclic bis(1,2-ethanediyl acetal); 3,20-Bis(ethylenedioxy)-19-norpregna-5(10)9(11)dien-17-ol; 17α-hydroxy-19-norpregna-5(10),9(11)-diene-3,20-dione 3,20-bis(ethylene acetal); 3,20-bis-ethylenedioxy-17α-hydroxy-19-norpregna-5(10),9(11)-diene; 3,20-bis-ethylenedioxy-17α-hydroxy-19-norpregna-4,9-diene; 3,3,20,20-bis(ethylene-dioxy)-17α-hydroxy-19-norpregna-5(10),9(11)-diene; 3,3,20,20-bis-(ethylenedioxy)-19-norpregna-5(10),9(11)-dien-17α-ol; 3,20-Bis(Ethylenedioxy)-19-Norpregna-5(10),9(11)-Dien-17-Ol; growthhormonereleasingpeptide |
| Fórmula molecular |
C24H34O5 |
| Número de registro CAS |
54201-84-2 |
| Estructura Molecular |
|
| SÃmbolos de Peligro |
|
| Códigos de Riesgos |
|
| Descripción de Seguridad |
|
|
ES
CN
CZ
DE
EN
FR
GR
HU
ID
IL
IN
IR
IT
JP
KR
MY
NL
NO
PL
PT
RU
SA
TR
